BC-CfE applauds France’s adoption of HIV treatment as prevention strategy

France has announced the adoption of the Treatment as Prevention® (TasP®) strategy, as pioneered by the BC Centre for Excellence in HIV/AIDS (BC-CfE), to combat HIV and AIDS.

France becomes the latest country to adopt TasP®, originally endorsed by the Joint United Nations Programme on HIV/AIDS (UNAIDS) in 2010. Since then, in 2011 China became the first nation to adopt the strategy, and the U.S. identified TasP® as a key strategy to achieve an AIDS-free generation in 2012. More recently, in July 2013, the World Health Organization fully incorporated TasP® in the new Global HIV Treatment Guidelines.

Read the full story

Leave a Reply

Scroll to Top

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below